Literature DB >> 9278385

The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases.

P Chen1, M Mayne, C Power, A Nath.   

Abstract

Human immunodeficiency virus (HIV) infection may cause a dementing illness. HIV-mediated dementia is clinically and pathologically correlated with the infiltration of activated macrophages and elevated levels of tumor necrosis factor (TNF)-alpha, both of which occur in an environment of small numbers of infected cells. We examined the possibility that HIV protein Tat, which is released extracellularly from infected cells, may induce the production of TNF-alpha. Tat induced TNF-alpha mRNA and protein production dose-dependently, primarily in macrophages but also in astrocytic cells. The TNF-alpha induction was NF-kappaB-dependent and could be eliminated by inhibiting protein kinase A or protein tyrosine kinase activity. In addition, Tat-induced TNF-alpha release was also linked to phospholipase C activation. However, Tat effects were independent of protein kinase C. These observations suggest that Tat may provide an important link between HIV and macrophage/glial cell activation and suggest new therapeutic approaches for HIV dementia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278385     DOI: 10.1074/jbc.272.36.22385

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 2.  Epidemiological evidence and molecular basis of interactions between HIV and JC virus.

Authors:  J R Berger; A Chauhan; D Galey; A Nath
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

3.  HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism.

Authors:  Kelly A Krogh; Elizabeth Lyddon; Stanley A Thayer
Journal:  J Neurochem       Date:  2014-09-18       Impact factor: 5.372

4.  HIV leucoencephalopathy and TNFalpha expression in neurones.

Authors:  K Rostasy; L Monti; S A Lipton; J C Hedreen; R G Gonzalez; B A Navia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

5.  Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia.

Authors:  Jadwiga Turchan-Cholewo; Filomena O Dimayuga; Qunxing Ding; Jeffrey N Keller; Kurt F Hauser; Pamela E Knapp; Annadora J Bruce-Keller
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

6.  Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation.

Authors:  Jadwiga Turchan-Cholewo; Filomena O Dimayuga; Sunita Gupta; Jeffrey N Keller; Pamela E Knapp; Kurt F Hauser; Annadora J Bruce-Keller
Journal:  J Neurochem       Date:  2008-11-19       Impact factor: 5.372

7.  HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes.

Authors:  Rémi Planès; Nawal Ben Haij; Kaoutar Leghmari; Manutea Serrero; Lbachir BenMohamed; Elmostafa Bahraoui
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

8.  Host and virus strain dependence in activation of human macrophages by human immunodeficiency virus type 1.

Authors:  Katarzyna Kazmierczak; Mary Jane Potash
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

9.  Cognitive impairment following high fat diet consumption is associated with brain inflammation.

Authors:  Paul J Pistell; Christopher D Morrison; Sunita Gupta; Alecia G Knight; Jeffrey N Keller; Donald K Ingram; Annadora J Bruce-Keller
Journal:  J Neuroimmunol       Date:  2009-12-08       Impact factor: 3.478

10.  Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death.

Authors:  Hong Kong; Quinton Baerbig; Laine Duncan; Nick Shepel; Michael Mayne
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.